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To assess whether pharmacologic coronary vasodilation 
Although intracoronary mean flow velocity measured in 
could provoke new left ventricular wall motion abnormal- 
ities in patients with single vessel coronary artery disease, 
systemic hemodynamics, coronary blood flow velocity and 
left ventricular wall motion were measured by two- 
dimensional echocardiography during administration of 10 
mg of intracoronary papaverine in 14 patients before and 
again immediately after left coronary angioplasty (group 
1). As a comparison with an intravenous method, left 
ventricular wall motion was analyzed after 0.56 mg/kg body 
weight of intravenous dipyridamole in a separate group of 
13 patients with single vessel coronary disease (group 2). 
Heart rate-blood pressure product increased 3% to 6% in 
papaverine-treated patients and 14 f 11% (p = NS) in 
dipyridamole-treated patients. No angiographic collateral 
vessels were present in either group. 
the 14 group 1 patients and in 5 normal control subjects 
during papaverine treatment increased from 125% to 
400% of basal flow velocity, papaverine induced new left 
ventricular wall motion abnormalities in only 5 of the 14 
patients before coronary angioplasty. In three of five pa- 
tients, left ventricular wall motion abnormalities persisted 
after successful coronary angioplasty. Four of the 14 pa- 
tients demonstrated augmentation of left ventricular wall 
motion with papaverine. After intravenous dipyridamole, 
only 3 of the 13 group 2 patients developed new left 
ventricular regional asynergy. 
(J Am Co11 Cardiol1989;13:1042-51) 
These data suggest that selective (papaverine) and, most 
likely, global (dipyridamole) augmentation of coronary flow 
alone does not reliably identify potential ischemic left 
ventricular regions affected by critical single vessel coro- 
nary artery disease. 
Coronary vasodilators may provoke new left ventricular wall 
motion abnormalities in regions supplied by stenotic coro- 
nary arteries. Dipyridamole-induced coronary hyperemia 
with echocardiographic assessment of left ventricular wall 
motion has been demonstrated as a feasible and reliable 
provocative test for myocardial ischemia in patients with 
coronary artery disease (l-3). Pharmacologic coronary hy- 
peremia can induce new asynergy in a region supplied by 
critical coronary stenosis in some patients, whereas in 
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others, myocardial regions supplied by coronary arteries 
with similar or nearly identical angiographic narrowings may 
demonstrate either normal or hypocontractile response pat- 
terns (1). The differences in left ventricular functional re- 
sponses among these patients have been attributed to dif- 
ferent degrees of coronary vasodilator reserve (I J-6). 
The mechanisms by which coronary hyperemia induces 
regional asynergy in patients with single vessel coronary 
artery disease are under study, but may include a transmural 
coronary steal with preferential redistribution of subendo- 
cardial to subepicardial perfusion. The increase in the trans- 
stenotic pressure gradient as a consequence of the increase 
in coronary flow may produce a decrease in distal perfusion 
with subendocardial ischemia and left ventricular dysfunc- 
tion (6). This hypothesis was supported, in part, by studies 
(I) measuring great cardiac vein efflux during dipyridamole- 
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induced hyperemia. However, in the particular patient sub- 
group of Picano et al. (I), angiographic collateral vessels 
were observed frequently in patients with dipyridamole- 
induced left ventricular wall motion abnormalities. Patients 
with coronary collateral vessels and isolated left anterior 
descending artery stenosis had impaired left ventricular wall 
motion, suggesting a different mechanism possibly involving 
a regional coronary “steal” of blood away from collaterally 
supplied regions. 
The purpose of this study was to examine selective 
coronary hyperemia and regional asynergy, testing whether 
intracoronary papaverine-induced hyperemia would result in 
left ventricular wall motion abnormalities similar to those 
observed with intravenous dipyridamole. If significant and 
consistent results were obtained in a subset of patients with 
isolated single vessel coronary artery disease, intracoronary 
selective hyperemia would prove to be a clinical laboratory 
tool useful for identifying physiologically significant coro- 
nary artery narrowings. 
Methods 
Study patients. The study group consisted of 32 patients. 
Fourteen patients (group I) with a single stenotic coronary 
artery underwent diagnostic coronary angiography and sub- 
sequent left anterior descending artery (n = I I) or circumflex 
artery (n = 3) angioplasty for angina1 chest pain. As a 
comparison with coronary vasodilation with intravenous 
dipyridamole and two-dimensional echocardiographic as- 
sessment (3), I3 patients (group 2) with angiographic single 
vessel coronary disease (left anterior descending artery, n = 
I I ; circumflex artery, n = 2) were retrospectively reviewed 
with regard to dipyridamole-echocardiographic left ventric- 
ular functional response before coronary angioplasty. Left 
ventricular functional data were unavailable after coronary 
angioplasty in this subgroup. Three patients in group I had 
regional akinesia and one patient in group 2 had severe 
inferior hypokinesia by echocardiography during rest condi- 
tions. No patient had angiographic collateral supply to the 
region of study. Patients with uncontrolled hypertension. 
valvular disease or evidence of severe left ventricular hyper- 
trophy by echocardiography were excluded. Five of the 32 
patients having no or minimal coronary artery disease were 
studied as a control group after diagnostic catheterization for 
chest pain syndromes. All medications were continued as 
prescribed by the physician. All subjects gave written in- 
formed consent to the protocol, which was approved by the 
Human Subjects Research Committee of St. Louis Univer- 
sity. 
Cardiac catheterization. For group I and the normal 
group, diagnostic cardiac catheterization was performed in a 
fasting state. Premeditation included diphenhydramine (25 
to 50 mg) and diazepam (2 to 5 mg). Suitable patients with 
single vessel coronary artery disease were then referred for 
coronary angioplasty at a separate procedure. Biplane left 
ventriculography was performed when available. Multiple 
projections of coronary angiograms were obtained in appro- 
priate angled views in all patients. Angiograms were visually 
reviewed by two independent experienced observers. Coro- 
nary artery disease was defined as >60% diameter narrowing 
in major epicardial vessels. In patients with normal coronary 
arteries, the evaluation of pharmacologic coronary hyper- 
emia and left ventricular function was performed >I5 min 
after the last radiographic contrast injection. 
Intracoronary papaverinelechocardiographic study. In the 
catheterization laboratory, baseline echocardiographic left 
ventricular wall motion was studied by standard two- 
dimensional echocardiographic technique with appropriate 
views continuously obtained before, during and for 3 min 
after bolus injection of IO mg of papaverine into the left 
coronary artery. A commercially available, wide angle, 
phased array imaging system (Hewlett-Packard model 
77020) with 3.5 and 5.0 MHz transducers was used. In 
baseline studies, standard echocardiographic views (long- 
axis. short-axis and apical two and four chamber) were 
obtained. 
Vidrottrpes vl‘ere unalyzed vtithout prior knowledge of 
curdinc catheterization findings. During coronary hyper- 
emia, new areas of abnormal left ventricular wall motion 
were identified and qualitatively assessed. as previously 
reported (3). Left ventricular regional wall motion was 
graded as hyperkinetic, normal, hypokinetic. akinetic or 
dyskinetic. 
Intracoronary Doppler flow velocity measurements. In I9 
patients (group I and normal group), intracoronary arterial 
flow velocity was measured at rest and during maximal 
papaverine-induced coronary hyperemia. An SF Judkins 
coronary guiding catheter (USC1 or Shiley, Inc.) was posi- 
tioned in the ostium of the left coronary artery. The catheter 
position was adjusted to avoid pressure damping. Intracoro- 
nary velocity was measured with a 2.5F Doppler catheter 
(Millar Instruments) with a 20 MHz pulsed Doppler crystal, 
as previously described (7,s). After the diagnostic study, the 
intracoronary velocity catheter was then inserted over a 300 
cm long, 0.014 in. (0.04 cm) guide wire through an 8F guiding 
coronary catheter. In the I4 patients undergoing coronary 
angioplasty (group I), 10,000 U of heparin was given before 
guide wire insertion (in the normal group, 3,000 U of heparin 
was given). In the five normal patients. the Doppler catheter 
was advanced <I cm proximal to the lesion or to the mid or 
proximal portion of the left anterior descending or circum- 
flex artery. This location was recorded on videotape for 
catheter replacement after coronary angioplasty. The Dop- 
pler velocity and hemodynamic signals were displayed and 
recorded on a photographic multichannel oscillographic re- 
corder (Electronics for Medicine, VRl2). Mean and phasic 
Doppler velocity signals were calibrated before catheter 
placement from an internally set arbitrary calibration of 0 to 
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100 cm/s, representing full scale deflection. In all patients, 
attempts were made to avoid large side branches (>12% 
diameter of major vessel) and eccentric catheter locations 
(causing unsuitable phasic signals). 
After stable, satisfactory mean and phasic velocity sig- 
nals were obtained, 10 mg of papaverine in 10 cc of normal 
saline solution was injected as a bolus over 3 s into the left 
coronary artery during continuous recording of hemody- 
namic variables, coronary artery flow velocity and echocar- 
diographic left ventricular wall motion through peak hyper- 
emia and for 120 s of recovery. Seven patients received 200 
pg of intracoronary nitroglycerin before administration of 
papaverine, with a 3 min equilibration and return to baseline 
before papaverine. After a 3 min equilibration period, a 
duplicate set of baseline and hemodynamic measurements 
was again obtained for the second intracoronary injection of 
10 to 12 mg of papaverine. This injection was used to assess 
reproducibility and to verify the maximal vasodilator effect 
of papaverine (7). 
Coronary angioplasty technique. After the precoronary 
angioplasty data were obtained, the Doppler catheter was 
then exchanged for an appropriately sized coronary angio- 
plasty balloon catheter (2.0 to 3.5 mm diameter) over the 
guide wire for coronary dilation. Translesional aortocoro- 
nary pressure gradients were measured when feasible (n = 
10 before dilation, n = 12 final). Coronary balloon inflations 
(usually three to five at 6 to 10 atm for 60 to 120s) were 
performed. After satisfactory angiographic and hemody- 
namic coronary angioplasty results were obtained, the cor- 
onary angioplasty catheter was again exchanged for the 
Doppler catheter and papaverine hyperemia-echocardio- 
graphic data were collected 30 to 45 min later in the identical 
manner as before coronary angioplasty. 
Intravenous dipyridamole methodology. In the 13 group 2 
patients with prior angiographic demonstration of single 
vessel coronary disease, two-dimensional echocardiographic 
left ventricular wall motion data were obtained at baseline 
and at peak hyperermic dipyridamole effect. Dipyridamole 
was infused intravenously at a rate of 0.14 mglkg per min 
over 4 min, for a total dose of 0.56 mglkg after a baseline 
echocardiographic study. Three minutes of isometric hand- 
grip exercise was then performed (9), and repeat two- 
dimensional echocardiographic examination of left ventric- 
ular wall motion was obtained. Two-dimensional parasternal 
short-axis images were recorded at the level of the mitral 
valve leaflets and the papillary muscles before the adminis- 
tration of intravenous dipyridamole. Apical two and four 
chamber images were recorded from the cardiac apex. For 
both papaverine and dipyridamole, the chest was marked for 
optimal transducer location for repositioning after interven- 
tion. 
Angiographic data analysis. Angiographic assessment of 
coronary stenosis for groups 1 and 2 was performed by 
computer-assisted caliper measurements from the projected 
35 mm coronary cineangiographic films on a General Electric 
Cap 12 projector. The diameters of the normal segments of 
the artery and the pre- and postcoronary angioplasty steno- 
sis diameters were obtained, with the absolute values com- 
puted with use of the known diameter of the guiding catheter 
as a calibrated reference. The percent diameter stenosis in 
both right and left anterior oblique views was averaged 
(when orthogonal views were available). The cross-sectional 
area computation of the normal portion of the vessel and 
minimal cross-sectional area of the stenosis assumed a 
circular geometry (cross-sectional area = 7~ (d/2)2, where d 
= diameter of stenosis in millimeters). It was also assumed 
that the rest diameter of the vessel was minimally affected by 
contrast medium or vasodilators at the time of velocity 
measurement. Overestimation of vasodilator reserve of ap- 
proximately 16% with papaverine-induced vessel diameter 
enlargement has been reported (10). The length of the lesion 
was ~0.5 cm in 12 patients undergoing coronary angioplasty. 
Coronary vasodilator reserve ratios. These ratios were 
computed as the mean peak hyperemic flow/mean basal 
mean flow velocity. Absolute mean and peak phasic coro- 
nary artery velocity responses, as well as diastolic flow 
velocity integral (area from aortic dicrotic notch to systolic 
upstroke (Fig. l), total diastolic time (Tu), time to peak 
velocity (Tpk), mean velocity acceleration (mACC) and first 
one-third (I& and first one-half (I,,,) of diastolic flow 
velocity integrals were also assessed. A percent increase 
from baseline value was also computed as ([peak-basal]/ 
basal value) x 100. 
Duplicate coronary responses to normal saline solution 
and papaverine demonstrated reproducibility of arterial flow 
velocity values over the measurement periods within ? 10%. 
Statistical method. Each patient served as his or her own 
control. Data were analyzed by one-way analysis of variance 
for repeated measures. Stepwise linear regression was used 
for correlation coefficients for coronary reserve ratios with 
angiographic data. In addition, when analysis of variance 
was significant, comparisons of the mean values were made 
with use of Duncan’s multiple range F statistic (11) and, 
where appropriate, paired and nonpaired Students t tests 
were performed. Chi-square test for discrete wall motion 
responses was applied. Statistically significant probability 
(p) values were accepted at p < 0.05. Results are expressed 
as mean values +- SD unless otherwise indicated. 
Results 
Clinical data (Table 1). The patient groups were similar 
with respect to age and gender distribution. Left ventricular 
wall motion abnormalities at rest were present in similar 
proportions in both the papaverine (group 1) and dipyri- 
damole (group 2) groups. No patient in group 1 and three 
patients in group 2 (Cases 3, 10 and 11) had inferior patho- 
logic Q waves on the rest electrocardiogram. Patient 1 in 
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Figure 1. Intracoronary Doppler velocity 
signal. The diastolic flow integral area 
used to estimate volumetric flou is rep- 
resented by the area I, bounded by the 
aortic (AO) dicrotic notch to the systolic 
upstroke. ACC, = mean velocity accel- 
eration: ECG = electrocardiogram; 
I,,? = half diastolic flow velocity integral; 
mVEL = mean velocity signal (scale 0 to 
100 cm/s): pVEL = phasic velocity sig- 
nal; T, = total diastolic time: T, = time 
to peak velocity; V, = peak phasic ve- 
locity. 
1 sec. 
I P-i 
i 200mmHg 1 OOcmlsec. 
group 1 had left bundle branch block. Nonspecific anterior or 
anterolateral ST changes were present in three patients in 
group 1 and in one patient in group 2. 
Hemodynamic response to vasodilation (Table 2). Rest 
and peak hemodynamic effects of both papaverine (group I) 
and dipyridamole (group 2) were similar, with systolic, 
diastolic and mean arterial pressure decreasing -5 2 8%, -4 
i 5% and -4 2 6% for group 1, the normal group and group 
2, respectively. The heart rate increased 7 ? 9%, 10 + 10% 
and 11 2 7%, respectively. with heart rate-blood pressure 
product increasing somewhat more for the dipyridamole 
group (14 2 11% versus 3 ? 14% and 6 + 4% for group 1 and 
the normal group, respectively, p = NS). 
Left ventricular wall motion abnormalities during coronary 
hyperemia (Table 3). Table 3 shows baseline and peak 
papaverine or dipyridamole hyperemic left ventricular echo- 
cardiographic ventricular wall motion. Data for wall motion 
analysis after coronary angioplasty were unavailable for the 
dipyridamole group (group 2). Five of the group 1 (papav- 
erine) patients (Cases 6, 7, 9, 11 and 12) demonstrated new 
left ventricular wall motion abnormalities during papaverine. 
Increased or hyperkinetic left ventricular wall motion was 
observed in Patients 1, 2, 5 and 14 during papaverine. After 
coronary angioplasty, improvement in wall motion was 
noted in Patients 7 and 9. 
For dipyridamole-induced hyperemia (group 2), new left 
ventricular wall motion abnormalities were present in Pa- 
tients 4, 7 and 8. No patient demonstrated improvement in 
wall motion. 
Angiographic data. The percent left anterior descending 
stenosis was similar in the patients in group 1 (papaverine) 
and group 2 (dipyridamole) with single vessel coronary 
artery disease (74 2 10% and 74 t 14% before coronary 
angioplasty for groups 1 and 2, respectively) (Table 1); after 
coronary angioplasty was performed, stenosis diameter im- 
proved by 23 t 22% and 27 t 12%, respectively (Table 1). 
Aortocoronary pressure gradients. available in 13 of the 14 
group 1 patients showed significant improvement (~30 mm 
Hg) in 10 patients after coronary angioplasty. Comparable 
quantitative angiographic data were present in group 1 and 
group 2 patients (11 of 13 angiograms in group 2 were 
available for analysis) (Table 4). 
Intracoronary velocity data (Table 4). Coronary vascular 
reserve before and after coronary angioplasty in group 1 
(papaverine) indicated a nonsignificant trend toward im- 
provement in coronary reserve ratio. One patient (Case 14) 
had a coronary vascular reserve ratio >3.5 before coronary 
angioplasty and three patients (Cases 3, 4 and 14) had a 
coronary vascular reserve ratio >3.5 after coronary angio- 
plasty (Table 4). No patient in group 1 with new regional 
asynergy had a coronary vascular reserve ratio >2.23 before 
coronary angioplasty and two patients with improved left 
ventricular wall motion after angioplasty had a coronary 
vascular reserve < 1.75. Patient 13 (Table 4) had reocclusion 
after angioplasty of the left anterior descending coronary 
artery and underwent successful coronary bypass surgery; no 
postcoronary angioplasty data were obtained in this patient. 
There were no significant differences with respect to 
absolute rest, peak phasic or mean flow velocity, mean 
acceleration time, total diastolic flow velocity integral, first 
third or first half velocity integrals between the normal group 
and the patients undergoing coronary angioplasty (group 1 
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Table 1. Clinical and Angiographic Data in 42 Patients 
Patient No. 
Age (yr) 
& 
Gender 
LVEF 
(%) LVWM 
Aottocoronary Gradient 
% Stenosis*+ (mm t-W 
Pre Post Pre Post 
Group 1 (intracoronary papaverine) 
1 59F 
2 65F 
3 36M 
4 40M 
5 40F 
6 45F 
7 40M 
8 59M 
9 63M 
10 49M 
11 57M 
12 54M 
13 66F 
14 79F 
Mean % SD 54 2 12 
Group 2 (intravenous dipyridamole) 
I 57F 
2 58F 
3 4lM 
4 66M 
5 7lM 
6 63M 
7 44M 
8 75M 
9 63M 
10 70M 
11 62F 
12 46F 
13 68F 
Mean + SD 602 10 
Normal group (intracoronary papaverine) 
I 39M 
2$ 48M 
3 67M 
4 49M 
5$ 69M 
Mean ? SD 54* 12 
43 
47 
60 
67 
59 
62 
85 
73 
73 
80 
62 
- 
- 
75 
66? 12 
518 
545 
635 
56 
78 
548 
74 
73 
68 
59 
451 
51 
468 
595 II 
59 
63 
66 
60 
68 
63 2 3 
AH 
IA 
NL 
NL 
AH 
NL 
IH 
NL 
NL 
NL 
IA 
NL 
AH 
NL 
19 16 
19 24 
82 17 
73 8 
57 21 
73 20 
90 26 
77 26 
74(C) 6 
58 IO 
58(C) 8 
82(C) 19 
84 100 
67 16 
74 t IO 23 ? 22 
NL 
NL 
NL 
IH 
NL 
NL 
NL 
NL 
NL 
NL 
AH 
NL 
IH 
95 
62 
80 
70 
80 
95 
65 
99(R) 
60 
95 
75 
70 
60(R) 
77 + I4 
NL 0 
AH 40 
NL 0 
NL 0 
NL 0 
50 
23 
25 
25 
IO 
30 
23 
23 
20 
50 
20 
- 
- 
272 12 
48 
40 
60 
45 
50 
65 
- 
50 
60 
45 
25 
- 
60 
40 
492 11 
18 
20 
30 
20 
20 
38 
IO 
28 
35 
10 
0 
0 
- 
35 
20* I2 
*Percent stenosis of left anterior descending artery unless indicated as right (R) or circumflex (C) coronary artery. +Pre and Post refer to before and after 
coronary angioplasty. $VeIocity data obtained in both left anterior descending and circumflex arteries. AH = anterior hypokinesia; F = female; IA = inferior 
akinesia; IH = inferior hypokinesia; LVEF = left ventricular ejection fraction (§echocardiographic); M = male; NL = normal; LVWM = left ventricular wall 
motion. 
and normal subjects) (Table 2). As in previous studies (12), 
the coronary vasodilator reserve ratio was impaired relative 
to normal for the coronary angioplasty group both before 
(2.14 + 1.05) (group 1) and after (group 1) coronary dilation 
(for the normal group, coronary vascular reserve = 3.22 + 
0.94, postcoronary angioplasty coronary reserve in group 1 
= 2.43 + 0.98, p < 0.05). The percent change in coronary 
velocity (both peak phasic and mean flow velocity) before 
coronary angioplasty, however, was significantly higher for 
normal arteries. 
Discussion 
The results of this study indicate that neither intracoro- 
nary papaverine nor intravenous dipyridamole consistently 
elicited new echocardiographically determined left ventric- 
ular regional wall motion abnormalities in patients with a 
critical single vessel coronary artery narrowing without 
collateral supply. Regional asynergy may be elicited by 
pharmacologic stimuli in some patients with single vessel 
disease (l), but the reported subgroup of patients with a 
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Table 2. Hemodynamic and lntracoronary Velocity Data During Coronarv Vasodilafion ~--- 
After PTCA 
-- _ _ -.- 
CON PAP 
_ ___ ___- --_ 
127 + 27 II9 + 24 
- 
- 
71 r II 6X + II 
- _ 
- 
_ -.--.--- 
Before t% 1) After (c/o A) 
- --.-_ 
-4 i 9 -3 2 I! 
-4 i 6 
-3 ? 6 - 
-4 : x -3 2 9 
-5 f 4 
4+x 
88 + IS 86 ? 14 
- 
71 -+ I2 7’ ? I3 
- - 
~51-8 -3 2 10 
-4 + 5 -- 
-4 r 6 - 
7 + 9 628 
10 + IO 
II i 7 
__. 
Before PTCA 
___ ~_ _. . -. -- 
CON PAP/DIP 
. -- __
SYS 
PTCA I?1 t 22 II< + IX 
NL I?5 + 21 I?1 t 24 
DIP 130 + 18 126 t 19 
DIA 
PTCA 68 ? 7 65 + 9 
NL 71 + 8 69 t 9 
DIP 79 t II 75 + 7 
MAP 
PTCA x7 + 10 82 + 9 
NI. 90 + I? 86 + 14 
DIP 96 t IO 9? + 9 
HR 
PTCA 73 t I4 79+_ I5 
NL 65 + ! 72 + 8 
DIP 67i 13 78t I2 
HR.SYS 
PTCA X.857 t !I97 9.050 I 2267 
NL 8.207 t 1438 8.644 ? 1126 
DIP F.705 -t 2384 9.793 2 2151 
Phasic VEI. 
PTCA 20 + 9 38+ IX 
NL I6 t 8 41-L I? 
Mean VEL 
PTCA I4 c 7 21 t 14 
NL IO t 4 30+ 10 
RCV 
PTCA 0.52 i 0.24 
NL 0.15 i- 0.016 
CVR 
PTCA ?.I4 2 I.05 
NL - 3 ?? 2 0.94* 
*p < 0.05 versus group I before/after angioplasty. CON = control: CVR = coronary vasodilatory reserve = (peak mean velocity [VELlibasal mean velocity): 
DIA = diastolic pressure (mm Hg); DIP r dipyridamole (group 2): HR = heart rate (beatcimin); HRSYS = heart rate-systolic pressure product (mm Hgbeats 
min ‘1; MAP = mean arterial pressure (mm Hg); NL = normal group; phasic VEL = peak phasic velocity; PTCA = coronary angioplasty (group I): RCV = ratio 
of coronary velocity normalized for mean arterial pressure (MAP) = (peak velocity/mean peak MAPlibasal velocity/mean basal MAP: SYS = systolic pressure 
(mm Hg): VEI. = veloclry: % A = ([papaverine-control]icnntrol)~lOO 
8.800 t 3.061 8.960 + 2848 
- 
3 fi I4 42 17 
624 - 
14 f II 
2x -+ IS 4X? 13 
- 
IO? 2 93 II? + 98 
204 t 104* 
I9 ? IO 36 + IO 
- 
II5 + I19 IIY? 85 
221 f 94* 
2.43 ? 0.98 
- 
- 
- 
- 
positive response had a more severely occluded artery with 
a higher proportion of collaterally supplied vessels. Unlike 
prior studies suggesting that coronary reserve correlated 
with left ventricular functional response, our study indicated 
that the intracoronary velocity determination of coronary 
reserve did not identify those patients prone to having 
inducible new wall motion abnormalities. Anatomic and 
angiographic data with regard to size of the vessel, lesion 
diameter or cross-sectional area and improvement after 
coronary angioplasty did not further identify patients with 
hyperemic wall motion abnormalities. As a comparison with 
previously reported studies (1,13,14) of intravenous methods 
used in similar patients, analysis of dipyridamole-induced 
echocardiographic responses was attempted. Dipyridamole 
has similar effects on the augmentation of coronary blood 
flow (1,131 and velocity (14) as does papaverine. 
Mechanisms of pharmacologic-inducible regional asynergy. 
In the presence of a critical coronary artery stenosis, in- 
creases in coronary blood flow by potent vasodilators such 
as papaverine, adenosine triphosphate, nitroglycerin and 
dipyridamole may cause a decrease in coronary perfusion 
pressure distal to the coronary stenosis (15,161. Thus, coro- 
nary vasodilators have the potential of producing subendo- 
cardial hypoperfusion secondary to a reduction in distal 
coronary perfusion, even though epicardial coronary blood 
flow is augmented. Alternatively, in patients with a critically 
narrowed vessel visualized by collateral flow, coronary 
vasodilators may produce regional asynergy by diverting or 
“stealing” blood from the collaterally supplied bed to a 
normal bed through dilation and reduction of distal coronary 
pressure in the normal coronary circuit (17). 
Picano et al. (I) demonstrated transient myocurdial dys- 
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Table 3. Echocardiographic Left Ventricular Wall Motion 
Responses to Pharmacologic Hyperemia in Groups I and 2 -. 
Before PTCA After PTCA 
Pt No. Base PAP Base PAP 
Group I 
I A H A H 
2 A H A H 
3 N N N N 
4 N N N N 
5 A H A H 
6 N H H H 
1 N H N N 
8 N N N N 
9 H D H A 
10 N N N N 
11 N H N H 
12 N H N H 
13 N N - - 
14 N U N N 
Base DIP Thallium 
Group 2 
I N N N 
2 N N N 
3 N N R 
4 N H N 
5 N N R 
6 N N N 
1 N LH R 
8 N LH R 
9 N N N 
10 N N N 
11 H H F 
12 N N N 
13 IH IH F - 
A = akinesia; Base = baseline study: D = dyskinesia: F = fixed thallium 
defect; Group 1 = angioplasty (PTCA) group with intracoronary papaverine 
(PAP): Group 2 = group with intravenous dipyridamoie (DIP): H = hypoki- 
nesia; I = inferior; L = lateral; N = normal; Pt = patient: R = redistribution 
thallium image: U = hyperkinesia. 
function during intravenous dipyridamole coronary vasodi- 
lation in 29 patients. In 19 patients with an 80% to 99% 
proximal isolated left anterior descending artery stenosis, 
coronary hyperemia during dipyridamole infusion induced 
asynergy in 9 and no asynergy in 10. The coronary artery 
stenosis of similar angiographic severity produced different 
reductions in coronary reserve, as determined by analysis of 
great cardiac vein efflux. The impairment of myocardial 
contractility appeared to be related to patients with reduced 
coronary reserve (1). 
The findings ofPicano et al. (I) were not duplicated in our 
study for at least ~four possible reasons: 1) in none of the 
patients with single vessel disease in our study was angio- 
graphically or acutely recruited (distal coronary artery oc- 
clusion pressure >35 mm Hg) collateral supply to the distal 
vessel present; 2) selective hyperemia with papaverine, 
rather than global hyperemia with dipyridamole, may cause 
a different systemic hemodynamiclcoronary, subepicardiall 
subendocardial flow distribution response; 3) the absolute 
cross-sectional area measurements in our study were com- 
puted from circular area (0.51 + 0.42 and 0.39 + 0.39 mm2 
versus 0.34 2 0.12 mm2 of Picano et al. [I] with assumption 
of an eliptical geometry); and 4) the use of great cardiac vein 
efflux versus arterial velocity ratios of coronary reserve may 
provide different results. In the present analysis, left ven- 
tricular wall motion responses to both papaverine and dipyr- 
idamole in patients without collateral flow were of similar 
proportions. Differences in the heart rate-blood pressure 
product tended to be higher in the dipyridamole study group 
as a result of the addition of isometric stress to maximize 
coronary flow. Despite a potentially greater degree of myo- 
cardial demand and reduced coronary reserve, inducible left 
ventricular wall motion abnormalities were minimal. 
The currentfindings are consistent with an elegant study 
by Fung et al. (ld), who used two-dimensional echocardiog- 
raphy to examine left ventricular wall motion in an open 
chest animal model during intravenous dipyridamole- 
induced hyperemia in an artery with an artificial critical 
circumflex artery stenosis. They found that left ventricular 
wall motion abnormalities were produced in only 55% of the 
dogs. The low frequency of echocardiographic left ventric- 
ular wall motion abnormalities was attributed to inadequate 
production of “true” ischemia with preservation of regional 
subendocardial blood flow. We also postulate that the lim- 
ited number of inducible wall motion abnormalities in our 
study is most likely due to maintenance of regional suben- 
docardial blood flow in patients with a critical single vessel 
coronary narrowing and no collateral flow (either visible or 
acutely recruitable). The increased left ventricular wall 
motion observed in several patients after administration of 
papaverine may represent a reflex increase in contractility, 
albeit of small magnitude, in response to systemic vasodila- 
tion or tachycardia. 
Coronary vasodilator reserve and left ventricular function. 
The mechanical behavior of the left ventricle in response to 
substantial coronary hyperemia through pharmacologic 
vasodilation reflects the cumulative hemodynamic severity 
of a stenosis more than the angiographic severity as assessed 
by percent luminal reduction, minimal cross-sectional area 
or coronary flow (or velocity) reserve in patients (1). The 
limitations of determining the physiologic importance of 
angiographic lesions are widely understood as a current 
unresolved methodologic dilemma in treating patients with 
coronary artery disease (19). To improve abnormal results 
related to severe coronary stenosis in our study, coronary 
angioplasty was performed and the measurements repeated. 
However, coronary flow velocity reserve after coronary 
angioplasty may not normalize in approximately 50% of 
patients (12), despite reports of improvement with thallium 
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Table 4. Angiographic and Coronary Reserve Data in Groups 1 and 2 Before and After Angioplasty 
Arterial Stenosis Diameter (mm) Cross-Sectional Area (mm) CVR 
Diameter 
Pt No. (mm) Before After Before After 1 %!I Before After 
Group I 
I 2 30 0.48 1.93 0.18 2.93 I .4.( 75.00 1.81 2.14 
2 2 60 0.55 I.98 0.23 3.07 I .33 72.37 2.27 1.00 
3 2.80 0.50 2.32 0.20 4.24 I.82 7x.31 2.11 3.88 
4 3 40 0.92 3.13 0.66 7.68 1 -._ II 70.65 2 .O(I 4.00 
5 2.90 I.25 2.29 I.22 4.12 I .04 45.57 2.6X 2.14 
6 2 50 0.68 2.00 0.36 3.14 I.33 66.25 1.64(WI 1.09 
7 2 3x 0.24 1.76 0.04 2.44 I.51 86.49 XXWI 1.67(l) 
8 2.72 0.63 2.01 0.31 3.18 I.39 68.92 1.61 1.79 
9 2.33 0.61 2.19 0.29 3.77 I .5x 72.34 056(W) I .05(I) 
IO 2.9X I.25 2.6X 1.23 5.65 I .43 53.33 2.65 2.91 
II 2.9 1.24 2.71 1.21 5 79 1.48 s4.35 2.19(W) 3.02 
I2 3 56 0.64 2.88 0.32 6.53 2.24 77.18 1.74(W) 2.32 
I3 2.94 0.47 - 0.17 I.25 
I4 2 50 0.83 2.10 0.53 3.46 I.18 60.71 5.23 3.95 
Mean i SD 2.72 r 0.31 0.74 ? 0.32 2.26 ? 0.38 0.51 f 0.42 4.12 t 1.46 I.50 ? 0.28 67.02 t II.15 2.14 = 1.05 2.43 ? 0.98 
Group 2 
I 2 80 0.14 1.40 0.02 I.54 I.26 90.00 
2 2 60 0.99 2.00 0.77 3.15 I.01 50.65 
3 3.20 0.64 2.40 0.32 4 52 1.76 73.33 
4 2.50 0.75 I .X8 0.44 2.76 I.13 60.00(W) 
5 2 70 0.54 2.43 0.23 4.64 I.89 77.78 
6 2.70 0.14 I.89 0.01 2.81 1.76 92.86 
7 3.00 1.05 2.31 0.x7 4.19 1.26 54.55(W) 
8 3.60 0.04 2.77 00 6.04 2.74 98.70(W) 
9 3.10 I .24 2.48 I.21 4.83 I.24 50.00 
IO 2.80 0.14 I .40 0.02 1.54 I .I6 90.00 
II 2.90 0.73 2.32 0.41 4.13 1.60 68.75 
12 - - - - - 
I3 _- - - - - - 
Mean ? SD 2.90 + 0.30 0.5x + 0.40 2.12 2 0.42 0.39 + 0.39 3.66 2 I.35 1.54 + 0.47 73.33 2 17.08 
CVR = coronary vasodilatory reserve (see text); 1 = improved left ventricular wall motion after angioplasty: Pt = patient: W = new left ventricular wall 
motion abnormality; A =: change in diameter (mm) and % change in diameter (mm) before and after angioplasty: - = data not available. 
perfusion (20) and radiographically determined flow reserve 
(21,22). Left ventricular wall motion improved in only two 
patients after reduction of epicardial luminal obstruction. 
Factors related to abnormal coronary reserve after coronary 
angioplasty include alteration of autoregulatory homeostasis 
involving the diseased small precapillary regulatory arte- 
rioles (23,24), vascular smooth muscle damage (25,26), en- 
dothelial vasomotor factor release or inhibition (27-3 l), local 
release of circulating factors directly affecting coronary 
vasomotor tone (30) or activation and release of platelet- 
mediated vasomotor products (28,29). 
In only one patient was the coronary vascular reserve 
value before coronary angioplasty above previously pub- 
lished (12,32) lower range normal limits (>3.5 units). After 
coronary angioplasty, coronary vascular reserve improved 
to above or near normal ranges in only three patients. No 
correlation with coronary reserve improvement and papav- 
erine-induced left ventricular wall motion abnormalities after 
coronary angioplasty was observed. The impaired coronary 
flow vasodilator reserve responses observed in this and 
other studies (12,31) most likely reflect the multiple mecha- 
nisms discussed and others yet to be defined. Nonetheless, 
failure to improve abnormal left ventricular wall motion 
initially after coronary angioplasty is consistent with residual 
attenuated coronary reserve after coronary angioplasty. In 
the two patients showing immediate wall motion improve- 
ment, coronary reserve did not appear to change in a 
consistent manner. 
Coronary flow responses to papaverine and dipyridamole. 
Studies of regional coronary blood flow have not directly 
compared intracoronary papaverine and intravenous dipyri- 
damole in the same patients. Intracoronary papaverine (10 
mg) increased coronary sinus (13) or coronary artery (14) 
flow velocity in patients with normal vessels and those with 
single vessel left anterior descending coronary artery steno- 
sis (400 + 100 and 75 + 40%, respectively) (14,33). Intrave- 
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nous dipyridamole increased coronary flow 400 2 240% and 
45 + 30%, for normal subjects and patients with coronary 
artery disease, respectively (12-14). Intracoronary dipyrida- 
mole increased coronary sinus flow 73% compared with an 
increase of 172% after intravenous dipyridamole in the same 
patients (13). The difference in coronary flow responses 
between routes of administration is attributed to increased 
myocardial oxygen demand with systemic effects (increased 
heart rate, cardiac output and pulmonary artery pressures) 
of dipyridamole. 
Limitations. Several limitations of clinical studies of this 
type deserve comment. These results may reflect the previ- 
ously acknowledged low sensitivity of two-dimensional 
echocardiographic assessment of left ventricular wall motion 
after coronary vasodilators for patients with varying degrees 
of coronary artery disease. The sensitivity increases propor- 
tionately with disease involvement, with studies (2,3,34-37) 
reporting sensitivity (individual study values averaged) for 
single, double and triple vessel coronary artery disease of 37, 
71 and lOO%, respectively. 
Artifacts and limitations of echocardiographic left ven- 
tricular wall motion analysis are well known and have been 
described in detail elsewhere (l-3). The few differences in 
angiographic (Table 1) and echocardiographic left ventricu- 
lar wall motion measurements used to identify inducible 
regional asynergy can be attributed to differences in tech- 
niques. Two-dimensional echocardiographic views used dur- 
ing the study were selected to visualize regions of interest, 
and wall motion in remote areas were not included. 
Although angiographic computations of cross-sectional 
area in this study are only approximate because quantitative 
digital radiographic techniques (38) were not yet available in 
our laboratory, coronary lumen dimensions were signifi- 
cantly reduced in all patients with coronary artery disease, 
with markedly reduced coronary vascular reserve in 13 of 
the 14 (group 1) patients undergoing coronary angioplasty. 
Suboptimal or subselective intracoronary vasodilatory drug 
administration may result in different concentrations being 
delivered to the target vessel. Attention was given to iden- 
tical catheter positioning for drug delivery. We attempted to 
duplicate catheter position proximal to the coronary angio- 
plasty site and use of signals with clearly demarcated phasic 
wave forms for analysis. 
Another possible explanation for the limited number of 
inducible left ventricular wall motion abnormalities would 
be an insufficient hyperemic stimulus with papaverine. The 
transient hyperemia may not provide sufficient duration or 
magnitude of oxygen debt to elicit contraction abnormalities. 
However, global hyperemia as predicted to occur with 
dipyridamole resulted in a similar low incidence of regional 
asynergy in a nearly identical group of patients. 
Conclusion. Although two-dimensional echocardiog- 
raphy appears to be useful in identifying patients with 
multivessel coronary artery disease (l-3), the immediate 
evaluation in the catheterization laboratory of left ventricu- 
lar regional asynergy induced by selective pharmacologic 
coronary hyperemia does not appear to be an adequate 
indicator of angiographically severe single vessel coronary 
stenosis. 
We thank the Mudd cardiac catheterization team, the echocardiography 
laboratory. Gregory Gabliani, MD, Joseph Bodet, MD and Yogesh Shah, MD, 
and Donna Sander for manuscript preparation. 
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